COVID-19 Vaccination and Admission Severity: Clinician-Rated WHO Severity and AI-Classified Lung Involvement on Chest X-Ray in a 2022 Indonesian Hospital Cohort
Jurnal Respirologi Indonesia · 10.03.2026 · 46 (1) · 48-59
DOI: 10.36497/0esqr016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Respirologi Indonesia, online erschienen am 10.03.2026. Verfasst von Amalia Nanda Mutia und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
COVID-19 remains a global public health concern. Differences in disease severity and hospitalization have been observed between vaccinated and unvaccinated individuals. This study aimed to evaluate COVID-19 vaccination status and clinician-assessed clinical severity as well as artificial intelligence (AI)-classified lung parenchymal involvement.
Methods
This retrospective cohort study included COVID-19 patients from January to December 2022. Clinical severity at admission was determined by World Health Organization criteria (mild, moderate, severe, critical). Lung parenchymal involvement was classified using a previously validated VGG16-based deep learning model applied to admission chest X-ray images. Vaccination status, verified through the national SatuSehat registry, was categorized as unvaccinated, single-dose, or two-dose; time since last vaccination and vaccine type were not consistently available.
Results
A total of 153 patients were included: 31 (20%) unvaccinated, 22 (15%) single-dose, and 100 (65%) two-dose recipients. Critical disease occurred in 12.9% of unvaccinated patients based on clinician assessment. No patients were classified as having severe lung parenchymal involvement by the AI model. Moderate lung involvement was more frequent in unvaccinated patients (29.0%) compared with single-dose (27.3%) and two-dose groups (7.0%). In multivariable ordinal logistic regression, two-dose vaccination was independently associated with lower odds of higher WHO clinical severity (adjusted odds ratio [aOR] 0.41; 95% confidence interval [CI] 0.19–0.86; P=0.018) and lower odds of more severe AI-classified lung involvement (aOR 0.32; 95% CI 0.14–0.71; P=0.005).
Conclusion
Two-dose vaccination was associated with lower clinician-assessed severity and reduced AI-classified lung parenchymal involvement at admission in this retrospective hospital-based cohort.
Zitieren
APA
Mutia, A. N., Yanti, B., Yus, T. M., & Geumpana, T. (2026). COVID-19 Vaccination and Admission Severity: Clinician-Rated WHO Severity and AI-Classified Lung Involvement on Chest X-Ray in a 2022 Indonesian Hospital Cohort. Jurnal Respirologi Indonesia, 46(1), 48-59. https://doi.org/10.36497/0esqr016
Vancouver
Mutia AN, Yanti B, Yus TM, Geumpana T. COVID-19 Vaccination and Admission Severity: Clinician-Rated WHO Severity and AI-Classified Lung Involvement on Chest X-Ray in a 2022 Indonesian Hospital Cohort. Jurnal Respirologi Indonesia. 2026;46(1):48-59. doi:10.36497/0esqr016
BibTeX
@article{Mutia2026,
author = {Mutia, Amalia Nanda and Yanti, Budi and Yus, Teuku Muhammad and Geumpana, Teuku},
title = {COVID-19 Vaccination and Admission Severity: Clinician-Rated WHO Severity and AI-Classified Lung Involvement on Chest X-Ray in a 2022 Indonesian Hospital Cohort},
journal = {Jurnal Respirologi Indonesia},
year = {2026},
volume = {46},
number = {1},
pages = {48--59},
doi = {10.36497/0esqr016}
}
EUVIMED